Hera Health Solutions is a pharmaceutical device company based in Memphis, Tennessee. It specializes in the research and development (R&D) of long acting treatments through subcutaneousâunder the skinâbiodegradable drug delivery implants. A full utility patent has been filed on its proprietary technology, that aims to eliminate painful, costly, and risky implant removal procedures by introducing a biodegradable material that resorbs into the body as the drug or hormone of choice is released. Bench studies have already been completed, and a preliminary protoype of the companyâs first product, Eucontra, has been produced with its manufacturing associate Nanafiber Solutions. The executive team is now prepping for the Food and Drug Administration (FDA) and World Health Organization (WHO) approval processes, and an international market launch. However, Eucontra is just the first of many biodegradable implantable products Hera Health seeks to create for the growing drug-delivery market. The company also aims to provide different solutions to the veterinary, opioid-addiction, hormone therapy, and breast cancer markets in the future.
Source
